Capital Markets Trading (UK)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-30,735
Closed -$1.86M 195
2021
Q3
$1.86M Buy
+30,735
New +$2.02M 0.03% 156
2021
Q2
Sell
-4,620
Closed -$301K 202
2021
Q1
$292K Buy
+4,620
New +$287K ﹤0.01% 197
2020
Q3
Sell
-29,870
Closed -$1.8M 189
2020
Q2
$1.76M Buy
+29,870
New +$1.79M 0.04% 134
2020
Q1
Sell
-16,596
Closed -$1.01M 228
2019
Q4
$1.06M Buy
+16,596
New +$950K 0.04% 138
2019
Q3
Sell
-12,247
Closed -$576K 201
2019
Q2
$555K Buy
12,247
+8,837
+259% +$412K 0.03% 176
2019
Q1
$163K Sell
3,410
-13,985
-80% -$697K 0.01% 172
2018
Q4
$904K Buy
+17,395
New +$935K 0.05% 148
2018
Q3
Sell
-19,961
Closed -$1.18M 180
2018
Q2
$1.1M Sell
19,961
-608
-3% -$32.8K 0.05% 145
2018
Q1
$1.3M Buy
+20,569
New +$1.32M 0.06% 136

Other funds holding BMY

Capital Markets Trading (UK)'s BMY Position: Q4 2021 in Review

Capital Markets Trading (UK) sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 30,735 shares — an estimated $1.86M sold.

Capital Markets Trading (UK) first reported a position in BMY in Q1 2018 and held it in 9 quarters. The position peaked at $1.86M in Q3 2021. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

  • Capital Markets Trading (UK) reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
  • Capital Markets Trading (UK) sold 30,735 Bristol-Myers Squibb shares in Q4 2021, an estimated $1.86M.
  • Capital Markets Trading (UK) first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 9 quarters.
  • Capital Markets Trading (UK)'s Bristol-Myers Squibb position peaked at $1.86M in Q3 2021.
  • 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Capital Markets Trading (UK)'s 13F filing for Q4 2021, filed 15 Feb 2022.